Ranbaxy Laboratories plans to divest its investments in the group companies of Malvinder Singh and family. At the current market price, the value of these investments is a little over Rs 300 crore. The company will also sell its 13% stake in Orchid Chemical and Laboratories, which is worth about Rs 135 crore at the current market price.
Under the earlier management, Ranbaxy had picked up 4.45% stake in Fortis Healthcare and 25% stake in Shimal Research Laboratories. At current price of Rs 163 per share, Ranbaxy’s stake in Fortis Healthcare is valued at Rs 230 crore. crackcrack| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: